No ADT for Men With Prostate Cancer, Comorbidities
Forgoing androgen deprivation therapy cuts rather than raises overall and cardiac mortality in certain patients with prostate cancer, depending on their comorbidities, according to a “Research Letter to the Editor” published in the Journal of the American Medical Association.
Source: Caring for the Ages - Category: Health Management Authors: Mary Ann Moon Source Type: news
More News: American Medical Association (AMA) | Cancer | Cancer & Oncology | Health Management | Prostate Cancer